Banner Publications MH200828 N141

Publications

Results found: 8227

Showing results: 8201 - 8227

The EMBO journal

Evidence for the involvement of pim-2, a new common proviral insertion site, in progression of lymphomas.

01-03-1989
Cell

Predisposition to lymphomagenesis in pim-1 transgenic mice: cooperation with c-myc and N-myc in murine leukemia virus-induced tumors.

24-02-1989
European journal of immunology

Alternative molecular form of human T cell-specific antigen CD27 expressed upon T cell activation.

01-02-1989
Immunogenetics

The primary structure of a feline class I gene: striking similarity to HLA-A.

01-01-1989
The EMBO journal

N-myc is frequently activated by proviral insertion in MuLV-induced T cell lymphomas.

01-01-1989
International journal of cancer. Supplement = Journal international du cancer. Supplement

Transgenic mice as a means to study synergism between oncogenes.

01-01-1989
The Journal of biological chemistry

Identification and characterization of a novel antigen complex on mouse mammary tumor cells using a monoclonal antibody against platelet glycoprotein Ic.

05-10-1988
Cancer research

Endocytosis and intracellular routing of an antibody-ricin A chain conjugate.

01-07-1988
Journal of virology

Regeneration of herpesviruses from molecularly cloned subgenomic fragments.

01-06-1988
The Journal of experimental medicine

Distinct molecular forms of human T cell receptor gamma/delta detected on viable T cells by a monoclonal antibody.

01-05-1988
Oncology (Williston Park, N.Y.)

Quality of life: what is it? How should it be measured?

01-05-1988
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Evaluation of breast conserving therapy: clinical, methodological and psychosocial perspectives.

01-04-1988
The EMBO journal

Tissue-specific expression of a vimentin--desmin hybrid gene in transgenic mice.

01-04-1988
The EMBO journal

Transcription of T cell receptor beta-chain genes is controlled by a downstream regulatory element.

01-03-1988
Progress in clinical and biological research

Subjective response criteria and quality of life.

01-01-1988
Journal of pharmaceutical and biomedical analysis

High-performance liquid chromatographic bioanalysis of anthracycline cytostatic drugs.

01-01-1988
Archives of virology

Provirus tagging as an instrument to identify oncogenes and to establish synergism between oncogenes.

01-01-1988
American journal of clinical oncology

The assessment of subjective response in prostatic cancer clinical research.

01-01-1988
Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer

A modular approach to quality-of-life assessment in cancer clinical trials.

01-01-1988
Clinica chimica acta; international journal of clinical chemistry

Improved method for the quantification of aminoglutethimide in urine samples.

30-10-1987
Oncogene research

Comparison of the human and mouse PIM-1 cDNAs: nucleotide sequence and immunological identification of the in vitro synthesized PIM-1 protein.

01-06-1987
Progress in clinical and biological research

Prospects for the future: quality of life evaluation in prostatic cancer protocols.

01-01-1987
Annals of oncology : official journal of the European Society for Medical Oncology

Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Oncotarget

Cooperation between BRCA1 and vitamin D is critical for histone acetylation of the p21waf1 promoter and growth inhibition of breast cancer cells and cancer stem-like cells

Breast Cancer Research: BCR

MEK inhibition as a strategy for targeting residual breast cancer cells with low DUSP4 expression

A single amino acid exchange, Arg-45 to Ala, generates an epidermal growth factor (EGF) mutant with high affinity for the chicken EGF receptor

Specific expression in mouse mesoderm- and neural crest-derived tissues of a human PDGFRA promoter/lacZ transgene

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.